HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A fatal case of pemphigus vulgaris with interstitial pneumonia occurring during gold therapy].

Abstract
We report a case of a 52-year-old female with therapy-resistant pemphigus vulgaris. She was treated with prednisone, azathioprine and gold sodium thiomalate. After administration of a total dose of 110 mg gold sodium thiomalate, she suddenly developed pityriasis rose-like drug eruptions and interstitial pneumonia and died despite intensive care including pulse therapy. In Japan, there have been 8 reported cases of pemphigus or bullous pemphigoid that developed interstitial pneumonia during gold therapy. In these 7 cases, interstitial pneumonia occurred after administration of 110 to 430 mg gold sodium thiomalate, and 4 cases died. This rate of death is higher than those with other diseases: i.e., 9 dead cases among 99 cases of interstitial pneumonia developing in patients with rheumatoid arthritis or asthma under treatment with gold sodium thiomalate. We think that it is necessary to reevaluate the combined treatment of sodium thiomalate and other immunosuppressive drugs such as azathioprine in pemphigus, because we also found 2 other fatal cases among the 4 reported ones with interstitial pneumonia.
AuthorsY Usuba, S Aiba, K Hashimoto, Y Tanita, K Sakai
JournalNihon Hifuka Gakkai zasshi. The Japanese journal of dermatology (Nihon Hifuka Gakkai Zasshi) Vol. 99 Issue 6 Pg. 725-30 (May 1989) ISSN: 0021-499X [Print] Japan
PMID2511359 (Publication Type: Case Reports, English Abstract, Journal Article, Review)
Chemical References
  • Gold Sodium Thiomalate
  • Azathioprine
  • Prednisone
Topics
  • Azathioprine (administration & dosage, therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Gold Sodium Thiomalate (administration & dosage, adverse effects)
  • Humans
  • Middle Aged
  • Pemphigus (drug therapy)
  • Prednisone (administration & dosage, therapeutic use)
  • Pulmonary Fibrosis (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: